This test analyzes genes linked to Progressive Myoclonic Epilepsy (PME) using advanced Next-Generation Sequencing (NGS) performed on an EDTA blood sample. Metropolis Healthcare uses high-precision sequencing to detect mutations that cause severe, progressive neurological symptoms. The test helps in confirming diagnosis, understanding the underlying genetic cause, and guiding clinical management. It is particularly useful for individuals with recurrent myoclonic seizures, cognitive decline, or a family history of PME.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0245
Frequently Asked Questions (FAQ's):
What does the PME Gene Panel include?
The PME panel at Metropolis Healthcare includes comprehensive sequencing of genes known to cause various forms of Progressive Myoclonic Epilepsy.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-depth NGS technology to accurately identify genetic variants associated with PME.
Who should consider taking this test?
Individuals experiencing unexplained myoclonic seizures, neurological deterioration, or those with a family history of PME should consider testing at Metropolis Healthcare.
Why is this genetic test important for PME?
The test from Metropolis Healthcare helps confirm the diagnosis, guides treatment plans, and provides valuable insights for prognosis.
What type of sample is required for this test?
An EDTA blood sample is collected, and Metropolis Healthcare extracts DNA for detailed genetic sequencing.
Can this test help in pediatric diagnosis?
Yes, Metropolis Healthcare often performs this panel for children showing early neurological symptoms or developmental regression.
How long does it take to receive results?
Turnaround time can vary, but Metropolis Healthcare aims to deliver accurate and comprehensive reports promptly.
Does this test assist in family counseling?
Yes, Metropolis Healthcare provides genetic insights that help families understand inheritance patterns and assess recurrence risks